Latest IBD Stories

ACG Experts Provide Insight on New IBD Therapies, Pregnancy and Pediatric Patient Concerns BETHESDA, May 27 /PRNewswire-USNewswire/ -- The American College of Gastroenterology announced the release of a new podcast series, "Audio Q&A on Inflammatory Bowel Disease," featuring ACG experts answering questions on topics of most concern to IBD patients, their caregivers and loved ones. In recognition of World Digestive Health Day--2010 the Year of IBD, the College's new podcasts emphasize...

ACG Marks World IBD Day, World Digestive Health Day 2010 with Emphasis on Living Well BETHESDA, Md., May 19 /PRNewswire-USNewswire/ -- The American College of Gastroenterology announces its support of World IBD Day and World Digestive Health Day, global awareness efforts that are bringing physician and patient groups together to raise awareness for Inflammatory Bowel Disease (IBD). With an emphasis on helping patients live well despite their IBD, the ACG is making the latest ACG practice...

ATLANTA, May 3 /PRNewswire/ -- UCB and the Inflammatory Bowel Disease Working Group (IBDWG) today announced the five recipients of the 2010 Research Awards in Inflammatory Bowel Disease (IBD) for Gastroenterology (GI) Fellows, each of whom will receive a one-year $40,000 research grant for their original clinical or basic research. The recipients were selected by the IBDWG Steering Committee and the awards were funded by a grant from UCB, Inc. A reception honoring the recipients will be...

BETHESDA, Md. and BOWIE, Md., April 28 /PRNewswire/ -- The American Gastroenterological Association (AGA) and MedAssurant, Inc., announce the launch of the largest patient registry in the GI field, the AGA Digestive Health Outcomes Registry(TM). The AGA Registry captures data and tracks outcomes related to inflammatory bowel disease (IBD) and colorectal cancer (CRC) prevention. Unique in the history of registry launches, the registry starts with a foundation of clinical data from more than...

CAMBRIDGE, Mass., April 15 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 - the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps...

PITTSBURGH -- An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory bowel disease (IBD) and in turn prevent progression to colon cancer, according to researchers at the University of Pittsburgh School of Medicine. Their findings are reported this week in Cancer Prevention Research, a journal of the American Association for Cancer Research.People with chronic inflammatory disorders such as IBD are at greater risk for...

ATLANTIC CITY, N.J., Feb. 17 /PRNewswire/ -- In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe...

New guideline identifies major risk factors in the development of colorectal cancer in children and adults with inflammatory bowel diseaseCertain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients, according...

People living with Inflammatory Bowel Disease (IBD) are known to be at high risk of blood clots when admitted to hospital during a flare-up of their disease but now new research by scientists at The University of Nottingham has shown that those who are not admitted to hospital during flare-ups are also at risk.The two main types of IBD are Ulcerative Colitis and Crohn's Disease which affect about one in every 250 people in the UK. The research published Feb. 9 in the medical journal, The...

Although inflammatory bowel disease (IBD) [comprising mainly Crohn's disease (CD) and ulcerative colitis (UC)] is thought to affect about 150 000 people in the United Kingdom, the prevalence of severe IBD is not known. Mortality following hospitalization for IBD is significant but little has been reported on long-term follow-up.A research article to be published on January 28, 2010 in the World Journal of Gastroenterology addresses this question. The research team from United Kingdom...